GENB
Generate Biomedicines, Inc.
13.49
-0.29 (-2.10%)
52w low 11.00
22.67 high
21.3% of range
Financial Analysis
| (USD) | Dec 24 | Dec 25 | Trend |
|---|---|---|---|
| Total Revenue | 20.46M | 31.89M | |
| Operating Expenses | 217.40M | 266.96M | |
| R&D | 175.31M | 224.70M | |
| SG&A | 42.09M | 42.26M | |
| Operating Income | -196.94M | -235.06M | |
| EBITDA | -163.71M | -208.49M | |
| Pretax Income | -181.17M | -222.80M | |
| Income Tax | 212.00K | 163.00K | |
| Net Income | -173.77M | -203.15M | |
| EPS Diluted | -2.09 | -2.18 | |
| Diluted Shares | 102.31M | 102.31M |
Revenue CAGR
+55.9%
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
+55.9%